FoxWayne Enterprises Acquisition filed with the SEC today to raise $50 million in an IPO.
The SPAC intends to target a biotechnology or telemedicine company in North America.
FoxWayne is led by Chairman, CEO and CFO Robb Knie, who is president, CEO and Chairman of Hoth Therapeutics, a biopharmaceuticals company.
The SPAC plans to list on the Nasdaq under FOXWU. Read more.
